Validation studies of Japanese administrative health care data: A scoping review

Author:

Yamana Hayato123,Konishi Takaaki34,Yasunaga Hideo3

Affiliation:

1. Data Science Center Jichi Medical University Shimotsuke Japan

2. Department of Clinical Data Management and Research, Clinical Research Center National Hospital Organization Headquarters Meguro Japan

3. Department of Clinical Epidemiology and Health Economics, School of Public Health The University of Tokyo Bunkyo Japan

4. Department of Breast and Endocrine Surgery, Graduate School of Medicine The University of Tokyo Bunkyo Japan

Abstract

AbstractPurposeLarge‐scale administrative health care databases are increasingly being utilized for research. However, there has not been much literature that validated administrative data in Japan; a previous review identified six validation studies published between 2011 and 2017. We conducted a literature review of studies that assessed the validity of Japanese administrative health care data.MethodsWe searched for studies published by March 2022 that compared individual‐level administrative data with a reference standard from another data source, as well as studies that validated administrative data using other data within the same database. The eligible studies were also summarized based on characteristics which included data types, settings, reference standard used, numbers of patients, and conditions validated.ResultsThere were 36 eligible studies, including 29 that used external reference standard and seven that validated administrative data using other data within the same database. Chart review was the reference standard in 21 studies (range of the numbers of patients, 72–1674; 11 studies conducted in single institutions and nine studies in 2–5 institutions). Five studies used a disease registry as the reference standard. Diagnoses of cardiovascular diseases, cancer, and diabetes were frequently evaluated.ConclusionsValidation studies are being conducted at an increasing rate in Japan, although most of them are small scale. Further large‐scale comprehensive validation studies are necessary to effectively utilize the databases for research.

Funder

Ministry of Education, Culture, Sports, Science and Technology

Ministry of Health, Labour and Welfare

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference61 articles.

1. Real World Data in Japan: Chapter I NDB

2. Real World Data in Japan: Chapter II The Diagnosis Procedure Combination Database

3. Survey of Japanese databases in Japan available for clinical/pharmacoepidemiology.Medical and healthcare database utilization committee Japanese Society for Pharmacoepidemiology. November 15 2022. Accessed March 24 2023.http://www.jspe.jp/committee/020/0210/

4. Health state information derived from secondary databases is affected by multiple sources of bias

5. Administrative database research infrequently used validated diagnostic or procedural codes

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3